Company

Protara Therapeutics, Inc. (TARA)

Standardized SEC financial data for Protara Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001359931 · NASDAQ · Biological Products, (No Diagnostic Substances).

Operating margin

-1000.0%

Net margin

-1000.0%

Return on equity

-29.2%

Free cash flow

-$56.5M

Current ratio

14.58×

EPS (diluted)

$-1.34

Ratios for fiscal year 2014, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
R&D expense	$12.0M	$21.1M	$16.8M	$25.0M	$31.7M	$42.6M
SG&A expense	$22.5M	$26.4M	$20.7M	$18.6M	$17.4M	$21.9M
Operating income	-$34.4M	-$47.5M	-$67.1M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$169.4M	$36.5M	$24.9M	$40.3M	$163.5M	$50.4M
Total current assets	$169.4M	$93.1M	$86.1M	$68.7M	$172.2M	$159.5M
Property, plant & equipment	$1.2M	$1.7M	$1.6M	$1.3M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$23.4M	-$34.5M	-$26.5M	-$37.6M	-$35.8M	-$56.4M
Capital expenditures	$884K	$596K	$120K	$45K	$63K	$94K
Free cash flow	-$24.3M	-$35.1M	-$26.6M	-$37.6M

Get TARA data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/TARA/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/TARA/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View TARA filings on SEC EDGAR →